Search Results 591-600 of 18664 for hepatitis

  1. Tipranavir (oral route) - Mayo Clinic

    Hyperlipidemia (high cholesterol or fats in the blood) or; Liver disease (eg, hepatitis B or C)—Use with caution. May make these conditions worse. Liver disease ...

  2. Insulin degludec (subcutaneous route) - Mayo Clinic

    Sharing needles or pens can result in transmission of hepatitis viruses, HIV, or other bloodborne illnesses. It is very important that your doctor will want ...

  3. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma - Mayo Clinic

    Active hepatitis B or C with uncontrolled disease. NOTE: a detailed ... NOTE: a detailed assessment of hepatitis B/C medical history and risk factors must be done ...

  4. Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma - Mayo Clinic

    * Active or chronic uncontrolled hepatitis B or hepatitis C infection. Patients with positive hepatitis B core antibody positive require negative polymerase ...

  5. Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome - Mayo Clinic

    ... hepatitis B (e.g. hepatitis B virus [HBV] surface antigen [HBsAg] reactive) or hepatitis C (e.g. hepatitis C virus [HCV] ribonucleic acid [RNA] [qualitative] ...

  6. Infectious Diseases A–Z: Should babies get their recommended vaccines at one time?

    Haemophilus influenzae type b; Hepatitis B (second dose); Polio · Pneumococcal · Rotavirus. Parents are encouraged to follow the Centers for Disease Control and ...

  7. Living With Cancer: Protecting yourself from melanoma - Mayo Clinic News Network

    Here are some ideas that may help if you'd like to write about your personal experiences. Should you be tested for hepatitis? Beating Esophageal Cancer Odds to ...

  8. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    can be enrolled if a confirmatory negative hepatitis C RNA test is obtained - Is seropositive for hepatitis B (defined by a positive test for hepatitis B ...

  9. Publications - Barry G. Rosser, Jr., M.D. - Mayo Clinic

    Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation. Liver Transpl. 2004 May; 10(5):599-606.

  10. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

    ... hepatitis B will be excluded unless the following criteria can be met: - If patient's serology shows hepatitis B virus core antibody (HbcAb)+ and hepatitis ...